$3.2M Grant Approved For Cancer, Tay-Sachs Research Efforts At UC Davis
The awards were part of the California Institute for Regenerative Medicine's competitive translational awards program, the goal of which is "to support the most promising stem cell-based projects and to help them accelerate that research out of the lab and into the real world, such as a clinical trial where they can be tested in people,” said Jonathan Thomas, chair of the CIRM board.
The Sacramento Business Journal:
Two UC Davis Efforts Get State Regenerative-Medicine Grants
The California Institute for Regenerative Medicine has approved more than $3.2 million in funding for two research efforts at the UC Davis Health System and School of Medicine in Sacramento. The larger award, $2.3 million, went to a team using stem cells to kill cancer cells in patients with aggressive malignancies. (Anderson, 3/22)